But if some of the newer drugs are beginning to improve cognition, it might be that we'll start evaluating cognition as part of a process in which we evaluate the effectiveness of drugs. In the case of schizophrenia, Green says treating cognition is just as important as treating hallucinations. So the cognitive deficits, which are really more subtle are more closely related to how well someone does in the community. So, if we have a new generation of drugs that works on this, we might expect to see better functional outcome with our patients. For Science Today, I'm Larissa Branin.
Preeclampsia is a disease which strikes mothers during pregnancy.
Dr. Susan Fisher of the University of California, San Francisco says preeclampsia, or toxemia, usually develops in young, first time mothers. Fisher says there's really no way to tell if a woman will develop preeclampsia before becoming pregnant. So there's really no way to diagnose preeclampsia until after a woman gets pregnant and after she develops the full blown disease. Fisher recommends pregnant women at risk, such as teens, women over 40 or of African-American descent, see an obstetrician regularly. For Science Today, I'm Larissa Branin.